1 |
Ronco AL, De Stefani E, Mendilaharsu M, Deneo-Pellegrini H (1996). Meat, fat and the risk of breast cancer: a case-control study from Uruguay. Int J Cancer, 65, 328-31.
DOI
|
2 |
Ronco AL, De Stefani E, Boffetta P, et al (1999). Vegetables, fruits, and related nutrients and risk of breast cancer: a case control study in Uruguay. Nutr Cancer, 35, 111-9.
DOI
|
3 |
Ronco AL, De Stefani E, Boffetta P, et al (1999). Vegetables, fruits, and related nutrients and risk of breast cancer: a case control study in Uruguay. Nutr Cancer, 35, 111-9.
DOI
|
4 |
Ronco AL, De Stefani E, Fabra A (2003). White meat intake and the risk of breast cancer: a case-control study in Montevideo, Uruguay. Nutr Res, 23, 151-62.
DOI
|
5 |
Ronco AL, De Stefani E, Boffetta P, et al (2006). Food patterns and risk of breast cancer: A factor analysis study in Uruguay. Int J Cancer, 19, 1672-8.
|
6 |
Ronco AL, Silveira S, De Stéfani E, Deneo-Pellegrini H, Mendilaharsu M (2007). Factores socioculturales y psicologicos y cancer de mama: un estudio caso-control en Montevideo, Uruguay. Biomedicina, 3, 6-17.
|
7 |
Ronco AL, Mendoza B, Varas X, et al (2008). Somatotype and risk of breast cancer: a case-control study in Uruguay. Braz J Epidemiol, 11, 215-27.
DOI
|
8 |
Ronco AL, Boeing H, De Stefani E, et al (2009a). A case-control study on fat to muscle ratio and risk of breast cancer. Nutr Cancer, 61, 466-74.
DOI
|
9 |
Ronco AL, Stoll M, De Stefani E et al (2009b). Rh factor, family history and risk of breast cancer: a case-control study in Uruguay. Cancer Det Prev, 32, 277-85.
DOI
|
10 |
Jaumandreu S, Varas X, Mezzera J, et al (2001). Cytologic diagnosis in palpable nodules of the breast. Arch Ginecol Obstet, 39, 148-53 (in Spanish).
|
11 |
Larsson SC, Mantzoros CS, Wolk A (2007). Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer, 121, 856-62.
DOI
|
12 |
Macaulay VM (1992). Insulin-like growth factors and cancer. Br J Cancer, 65, 311-20.
DOI
|
13 |
McTernan PG, Anderson LA, Anwar AJ, et al (2002). Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences. J Clin Endocrinol Metab, 87, 1327-36.
DOI
|
14 |
Maiti B, Kundranda MN, Spiro TP, Daw HA (2010). The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat, 121, 479-83.
DOI
|
15 |
Michels KB, Solomon CG, Hu FB, et al (2003). Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care, 26, 1752-8.
DOI
|
16 |
Muck BR, Trotnow S, Hommel G (1975). Cancer of the breast, diabetes and pathological glucose tolerance. Arch Gynakol, 220, 73-81.
DOI
|
17 |
Muti P, Quattrin T, Grant BJ, et al (2002). Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev, 11, 1361-8.
|
18 |
Novosyadlyy R, Lann DE, Vijayakumar A, et al (2010). Insulinmediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res, 70, 741-51.
DOI
|
19 |
Parkin DM, Whelan SL, Ferlay J, et al (2002). Cancer incidence in five continents, vol 8. IARC Scientific Publications No. 155, IARC, Lyon.
|
20 |
Pasanisi P, Berrino F, De Petris M, et al (2006). Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer, 119, 236-8.
DOI
|
21 |
Potischman N, McCulloch CE, Byers T, et al (1991). Associations between breast cancer, plasma triglycerides, and cholesterol. Nutr Cancer, 15, 205-15.
DOI
|
22 |
Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10. Lyon, France: International Agency for Research on Cancer. Available at: http://globocan.iarc.fr. [Accessed 17.08.2010].
|
23 |
Food and Agricultural Organization (2010). http://faostat.fao. org/site/610/Desktop Default.aspx? PageID=610#ancor [Accessed 30.04.10].
|
24 |
Freund E (1885). Diagnosis des Carcinomas. Wiener Medizinische, B1, 268 (in German).
|
25 |
Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004). Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst, 96, 1152-60.
DOI
|
26 |
Glicksman AS, Rawson RW (1956). Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer, 9, 1127-34.
DOI
|
27 |
Goodwin PJ, Ennis M, Pritchard KI, et al (2002). Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol, 20, 42-51.
DOI
|
28 |
Grote VA, Becker S, Kaaks R (2010). Diabetes mellitus type 2 - an independent risk factor for cancer? Exp Clin Endocrinol Diabetes, 118, 4-8.
DOI
|
29 |
Guastamacchia E, Resta F, Mangia A, et al (2003). Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord, 3, 205-9.
DOI
|
30 |
Hamelers IH, Steenbergh PH (2003). Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr Relat Cancer, 10, 331- 45.
DOI
|
31 |
Hanley AJ, Festa A, D'Agostino Jr RB, et al (2004). Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes, 53, 1773-81.
DOI
|
32 |
Cauley JA, Zmuda JM, Danielson ME, et al (2003). Estrogen metabolites and the risk of breast cancer in older women. Epidemiology, 14, 740-4.
DOI
|
33 |
Hirose K, Toyama T, Iwata H, et al (2003). Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev, 4, 239-46.
|
34 |
Capasso I, Esposito E, Pentimalli F, et al (2011). Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther, 10, 1240-3.
|
35 |
Carter JEL (2002). The Heath-Carter anthropometric somatotype- Instruction Manual. Surrey, Canada, TeP and Rosscraft.
|
36 |
Chaudhuri PK, Chaudhuri B, Patel N (1986). Modulation of estrogen receptor by insulin and its biologic significance. Arch Surg, 121, 1322-5.
DOI
|
37 |
Connolly BS, Barnett C, Vogt KN, et al (2002). A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer, 44, 127-38.
DOI
|
38 |
De Rose EH, Pigatto E, Celi R (1984). Kinanthropometry, physical education and sport training. SEED, Brasilia. (in Portuguese)
|
39 |
De Stefani E, Ronco AL, Mendilaharsu M, Guidobono M, Deneo-Pellegrini H (1997a). Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidemiol Biomark Prev, 6, 573-81.
|
40 |
De Stefani E, Correa P, Ronco A, et al (1997b). Dietary fiber and risk of breast cancer. Nutr Cancer, 28, 14 9.
DOI
|
41 |
De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, Ronco AL (1998). Essential fatty acids and breast cancer: a case-control study in Uruguay. Int J Cancer, 76, 491-4.
DOI
|
42 |
Falk RT, Fears T, Xu X, et al (2005). Urinary estrogen metabolites and their ratio among Asian American women. Cancer Epidemiol Biomarkers Prev, 14, 221-6.
|
43 |
American College of Radiology (1998). Breast imaging reporting and data system (BI-RADS). 3rd ed., American College of Radiology, Reston, VA.
|
44 |
Faulkner J (1968). Physiology of swimming and diving. In Falls H: Exercise Physiology. Academic Press, Baltimore.
|
45 |
Feig SA (1999). Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging. Semin Nucl Med, 29, 3-15.
DOI
|
46 |
Agnoli C, Berrino F, Abagnato CA, et al (2010). Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis, 20, 41.
DOI
|
47 |
Bjorge T, Lukanova A, Jonsson H, et al (2010). Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev, 19, 1737-45.
DOI
|
48 |
Bray F, Mc Carron P, Parkin DM (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res, 6, 229-39.
DOI
|
49 |
Breslow NE, Day NE (1980). Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. IARC Sci.Publ. 32. IARC, Lyon.
|
50 |
Campagnoli C, Pasanisi P, Peris C, et al (2008). Insulin-like Growth Factor-I and Breast Cancer: Epidemiological and Clinical Data. In: Pasqualini JR (ed) Breast Cancer: Prognosis, Treatment and Prevention. 2nd ed. Informa Healthcare, New York.
|
51 |
Warburg O (1930). The metabolism of tumors. Constable Press, London.
|
52 |
Campbell KL, Westerlind KC, Harber VJ, Friedenreich CM, Courneya KS (2005). Associations between aerobic fitness and estrogen metabolites in premenopausal women. Med Sci Sports Exerc, 37, 585-92.
DOI
|
53 |
Campbell KL, Westerlind KC, Harber VJ, et al (2007). Effects of aerobic exercise training on estrogen metabolism in premenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev, 16, 731-9.
DOI
|
54 |
Varas X, Leborgne F, Leborgne JH (1992). Non palpable, probably benign lesions: role of follow-up mammography. Radiology, 184, 1409-14.
|
55 |
Verheus M, Peeters PH, Rinaldi S, et al (2006). Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer, 119, 659-67.
DOI
|
56 |
Vona-Davis L, Howard-McNatt M, Rose DP (2007). Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer. Obes Rev, 8, 395-408.
DOI
|
57 |
Xue F, Michels KB (2007). Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr, 86, 823-35.
DOI
|
58 |
Westerlind KC, Williams NI (2007). Effect of energy deficiency on estrogen metabolism in premenopausal women. Med Sci Sports Exerc, 39, 1090-7.
|
59 |
Wilson AM, Ryan MC, Boyle AJ (2006). The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol, 106, 291-7.
DOI
|
60 |
World Cancer Research Fund/American Institute for Cancer Research (2007). Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC.
|
61 |
Ronco AL, De Stefani E, Aune D, et al (2010a). Nutrient patterns and risk of breast cancer in Uruguay. Asian Pac J Cancer Prev, 11, 519-24.
|
62 |
Ronco AL, De Stefani E, Stoll M (2010b). Hormonal and metabolic modulation through nutrition: towards a primary prevention of breast cancer. The Breast, 19, 322-32.
DOI
|
63 |
Ronco AL, De Stefani E, Deneo-Pellegrini H, et al (2010c). Dietary patterns and risk of ductal carcinoma of the breast: a factor analysis in Uruguay. Asian Pac J Cancer Prev, 11, 1187-93.
|
64 |
Schott S, Schneeweiss A, Sohn C (2010). Breast cancer and diabetes mellitus. Exp Clin Endocrinol Diabetes, 118, 673-7.
DOI
|
65 |
Ronco AL, De Stefani E (2010d). Diabetes, overweight and risk of breast cancer: a case-control study in Uruguay. Proceedings of the XVI World Congress of the Senologic International Society. Valencia, Spain, October 20-22nd, 2010.
|
66 |
Rosato V, Bosetti C, Talamini R, et al (2011). Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol, 22, 2687-92.
DOI
|
67 |
Sachdev D, Yee D (2001). The IGF system and breast cancer. Endocr Relat Cancer, 8, 197-209.
DOI
|
68 |
Sinagra D, Amato C, Scarpilta AM, et al (2002). Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci, 6, 55-9.
|
69 |
Soler M, Chatenoud L, Negri E, et al (1999). Hypertension and hormone related neoplasms in women. Hypertension, 34, 320-5.
DOI
|
70 |
Tsugane S, Inoue M (2010). Insulin resistance and cancer: epidemiological evidence. Cancer Sci, 101, 1073-9.
DOI
|
71 |
United Nations Organization (2009), Human development index rankings. Available at: http://hdr.undp.org/en/statistics/. [accessed 27.04.10].
|
72 |
U.S. Census Bureau (2010). International data base, http://www. census.gov/ipc/www/idb/ country.php [accessed 30.04.10].
|
73 |
Reaven GM (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37, 1595-607.
DOI
|
74 |
Rock CL, Demark-Wahnefried W (2002). Can lifestyle modification increase survival in women diagnosed with breast cancer? J Nutr, 132, 3504-7S.
DOI
|